HR Digest

JULY 25, 2024

to court after he was not provided the option to refuse the use of the HireVue video interview technology or Affectiva’s artificial intelligence analysis program when he interviewed for a position with the organization in 2021. What is the HireVue Technology That Was Used in the CVS-Job Applicant Settlement?

Process 52

Process Supply Chain Pharmaceuticals Efficiency 52

The Horizons Tracker

APRIL 11, 2023

“This suggests that insiders appear to put more stock into technological innovation, which perhaps they perceive as more tangible, than in strategic actions or corporate communications that reflect a focus on market-based innovations.” Preannouncing an additional new product increases the IPO value by $34.88

IPO 114

IPO Reference Pharmaceuticals Document 114

Eric Jacobson

JULY 8, 2024

AI enables computers and machines to simulate human intelligence and problem-solving capabilities AI technology can process substantial amounts of data in ways, unlike humans. Revolutionize health care, making individualized, targeted pharmaceuticals more affordable. But to do so, we must master ourselves.

Tacit Knowledge 81

Tacit Knowledge Competitive Advantage Pharmaceuticals Magazine 81

The Horizons Tracker

FEBRUARY 22, 2022

That we’re still largely waiting for such an immersive world to take hold, despite much-hyped initiatives, such as Second Life, perhaps underlines the difficulties the technology has had in keeping pace with such a vision. It’s a market that is already worth $3.1 Digital twins.

Stephenson 109

Stephenson Wireless Christensen Automotive 109

N2Growth Blog

FEBRUARY 4, 2015

Here is the rub and the reason why adopting this principle is so critical: in our experience, the priority initiatives turn out to be on new product, service, customer, and technology initiatives accompanied by an assumption that the organization has the capabilities to execute them. Engineered to Win.

Process 150

Process Agility Competitive Advantage Strategy 150

First Friday Book Synopsis

MARCH 21, 2012

An entrepreneur and veteran of the computer industry, Frank Moss spent his career bringing innovative technologies to market. Ten years ago he set out to make a broader contribution to the world, leading him to cofound a cancer drug discovery company and then to the MIT Media Lab, where he served as director from 2006 [.].

Entrepreneur 80

Entrepreneur Media Technology Innovation 80

The Horizons Tracker

SEPTEMBER 15, 2019

The current political conditions make Britain a unique test market; the more local independent entrepreneurs we can attract to join our global community, the more interesting and innovative applications we can build with British businesses through e-Residency.

Pharmaceuticals 69

Pharmaceuticals Entrepreneur Politics Globalization 69

Strategy Driven

JULY 13, 2011

It turned out that the unit was driving profits by raising prices and cutting marketing and advertising expenditures. Higher prices and reduced advertising created an opening for competitors to take away market share, which they did. So while profits were rising and ROIC was high, market share was declining.

ROIC 62

ROIC Balanced Scorecard Metrics McKinsey 62

The Horizons Tracker

SEPTEMBER 10, 2021

By contrast, firms operating in areas such as online retail, pharmaceuticals, and information and communications technology, have all thrived. Smaller firms were especially affected by the virus because they rely far more on face-to-face interactions with customers for both marketing and transactions. Face-to-face interactions.

Pharmaceuticals 54

Pharmaceuticals Transportation Retail Long-term 54

HR Digest

MARCH 8, 2020

They offer hosting and management services, along with marketing and customer service management. It conducts clinical trials on behalf of its pharmaceutical clients and provides regulatory, consulting, and market access to expedite the drug approval process. It offers Linux, cloud, container, and Kubernetes technologies.

Company 85

Company Insurance Travel Software 85

Strategy Driven

JANUARY 24, 2011

Closing the Execution Gap : How Great Leaders and Their Companies Get Results by Richard Lepsinger If an organization can’t execute its plans and initiatives, nothing else matters: not the most solid, well thought-out strategy, not the most innovative business model, not even technological breakthroughs that could transform an industry.

Execution 67

Execution Company 360-Degree Feedback Cooper 67

Strategy Driven

MARCH 18, 2011

In The Essential Advantage : How to Win with a Capabilities-Driven Strategy , Booz & Company’s Paul Leinwand and Cesare Mainardi maintain that success in any market accrues to firms with a coherence premium – a tight match between their strategic direction and the capabilities that make them unique. Let’s go after it.”

Resources 51

Resources Industry System Strategy 51

Harvard Business Review

FEBRUARY 17, 2011

Venture capitalists are increasingly interested in emerging markets, and in working with local funds based in those markets (despite the fact that reverse innovation in venture capital seems counterintuitive). In contrast, emerging-market VCs such as Nadathur Holdings (established in 2000 by N.S.

Marketing 15

Marketing Venture Capitalist Biotechnology IPO 15

Harvard Business Review

JULY 17, 2014

When Raja Rajamannar became CMO of MasterCard Worldwide in 2013, he moved quickly to transform how the credit card giant measures marketing. But the real power and full potential of data was not being fully realized by marketing. As an ingredient brand, Intel often struggled to link marketing to P&L impact. Inside Intel.

Finance 15

Finance Marketing P&L ROI 15

Harvard Business Review

JUNE 7, 2012

Take technology providers' technical support, with its long hold times "hopelessly complex interactions." The numbers are enough to make the apple pop right out of the marketer's eye. Clearly that's not quite the target market for a new washer and dryer. Medical supply and equipment costs are abating under market pressure.

Disruptive Innovation 22

Disruptive Innovation Innovation Pharmaceuticals Class 22

Harvard Business Review

MARCH 11, 2018

That rule of life is no secret to pharmaceutical companies across the globe. Japan remains the world’s second-biggest pharmaceuticals market, behind only the United States and China. The Japanese market also is expected to grow annually. Older people need more medicine. Read More from the Government of Japan.

Pharmaceuticals 8

Pharmaceuticals Health Care Industry Content 8

Harvard Business Review

MARCH 8, 2011

In a world with severe healthcare resource constraints, mobile digital technology can be a major " force multiplier." In this respect, health care is no different from other economic sectors that have gained enormous efficiencies and improved outcomes through the use of modern information and communications technologies (ICT).

Wireless 17

Wireless Health Care Pharmaceuticals Business Model 17

Leading Blog

NOVEMBER 15, 2024

New technologies, shifting regulations, and a heightened focus on biotechnology and pharmaceuticals meant that professionals needed to stay ahead of the curve. I saw a gap in the market—a demand for comprehensive, high-quality training that could empower individuals and drive progress in the industry.

Uncertainty 380

Uncertainty Biotechnology Industry Training 380

Harvard Business Review

MAY 20, 2014

financial services sector went from 13,000 of independent banks to half that number, while the top ten banks grew from 20% market share to 60%. As of 2013, the top ten banks had 70% of the market. In pharmaceuticals, the largest company, Pfizer, is the result of decades of mergers. In the guitar business , too.

Pharmaceuticals 15

Pharmaceuticals Banking Chemicals Entrepreneur 15

Harvard Business Review

MAY 7, 2015

Recently, information technology research and advisory company Gartner compiled a list of top 10 strategic technology trends. This information improved marketing campaign targeting, as well as sales force targeting. In the pharmaceutical industry, technology is transforming the sales process. Computing everywhere.

Trends 8

Trends Technology Pharmaceuticals Team 8

Harvard Business Review

MARCH 12, 2012

His company is quite respected in the sustainability community both for its progressive social equity policies and for green technology that limits the environmental impacts of his company's manufacturing activities. So I asked: Do you foresee a time when you'd willingly provide access to your leading green technology to your competitors?

Co-Opetition 17

Co-Opetition Company Brandenburger Game Theory 17

Harvard Business Review

JULY 8, 2016

The difference between displacement (outperforming existing market incumbents at their own game) and disruption (changing the game) is strategically important, no matter how similar the pain they cause is. Displacement generally is easier to combat than disruption.

Business Model 14

Business Model Innovation Company Apparel 14

Harvard Business Review

AUGUST 3, 2012

They might make a targeted acquisition here or there, form an alliance now and again, or license in some specialized technology, but by and large they made their own drugs, supporting big, fully staffed research labs, which they would then market themselves. As yet, the facts don't seem to substantiate the fears.

Licensing 15

Licensing Depreciation Pharmaceuticals Budgeting 15

Harvard Business Review

APRIL 16, 2012

Strategic cash provides more flexibility concerning the timing and pricing of potential acquisitions; having cash on hand is the best insurance that CFOs will be able to respond with alacrity to opportunities and not be subject to the vagaries of the financial markets. Facilitate Investments. Arguments Against Strategic Cash.

Company 15

Company Cost of Capital Finance Long-term 15

Harvard Business Review

JUNE 7, 2012

Take technology providers' technical support, with its long hold times "hopelessly complex interactions." The numbers are enough to make the apple pop right out of the marketer's eye. Clearly that's not quite the target market for a new washer and dryer. Medical supply and equipment costs are abating under market pressure.

Disruptive Innovation 15

Disruptive Innovation Innovation Pharmaceuticals Class 15

Harvard Business Review

AUGUST 23, 2012

These hurdles aren't unique to financial services — insurance, pharmaceuticals, health care and government all face regulation, to name a few examples. without any compliance process or technology in place.". Employees, particularly those in the sales and marketing functions, need to know the rules of the road," Langford says.

Compliance 17

Compliance Media Compliance Officer Policies 17

Harvard Business Review

NOVEMBER 9, 2011

COOs are relatively common in service industries such as financial services, energy, information technology and telecommunications, but in manufacturing sectors — such as automotive, chemical, and pharmaceutical companies — they are relatively rare.

COO 16

COO Sample Telecommunications Automotive 16

Harvard Business Review

AUGUST 29, 2011

We discovered some of these pushes and pulls in our research for our upcoming book, Winning the War for Talent in Emerging Markets: Why Women Are the Solution. Women are critical contributors in finance, info-tech, pharmaceutical research, and other industries that are driving the growth of India Inc. We do all of them.".

Stress 20

Stress Human Resources Pharmaceuticals Finance 20

Harvard Business Review

MAY 26, 2016

Firms engage in political “rent seeking”—lobbying for regulations that provide them sheltered markets—rather than competing on innovation. Perhaps profits are rising because firms are increasingly making profitable investments in new technology, in IT, or in their organizational capabilities.

Pharmaceuticals 15

Pharmaceuticals Politics Price Chemicals 15

Harvard Business Review

JANUARY 26, 2011

Companies included in the ETF include major airlines, pharmaceuticals, industrials, and technology. By the end of October in 2010, the market value of the 100 constituent stocks reached 582 billion RMB, accounting for 31% of the total market value of the Shanghai Stock Exchange's A shares.

Long-term 15

Long-term Sample Report Pharmaceuticals 15

Harvard Business Review

MAY 24, 2012

Pharmaceutical manufacturers, insurers, and retailers invest millions in risk avoidance. But in the era of Big Data and decision-making at the desktop, it's vexing to think that any company with significant technology investments would allow the all-too-human traits of ownership debates and subjective opinion to override robust data analysis.

Merchandising 15

Merchandising Risk Management Supply Chain Retail 15

Harvard Business Review

JANUARY 31, 2013

First we see major shifts in demand: developing economies such as China and India are morphing from the world's source of low-cost manufacturing capacity to the world's best market opportunities. All over the world, automakers are mastering new drive train technologies. Innovations Are Changing The Way We Design Products.

Globalization 13

Globalization Supply Chain Pharmaceuticals McKinsey 13

Harvard Business Review

JULY 12, 2011

Long term commitment in a world where the technology is advancing almost on a daily basis is difficult to maintain. Boston Scientific a few years back launched a secret project to reverse-engineer the technology of its single-source supplier of coronary stents. Judge McVeigh's punch line applies across a range of industries.

Management 15

Management Airlines How To Pharmaceuticals 15

Harvard Business Review

MAY 16, 2011

True collaboration always has open-ended elements — ranging from precisely how new innovations will be implemented, to how products will fare in the market, and even to what priorities partners will pursue in the face of changes in the environment. Google uses a different approach to working with multiple external parties.

Software 20

Software Licensing Long-term Telecommunications 20

Harvard Business Review

OCTOBER 27, 2015

In most companies, marketers are in charge of assessing the competition. Because of this, close to 60 percent of all competitive intelligence professionals report to marketing. Yet the majority of marketers fail to use their competition analysts strategically, instead using them to gather more “recon” data.

Marketing 8

Marketing Competitive Intelligence Porter How To 8

Harvard Business Review

MARCH 18, 2018

Why the Pharmaceutical Industry Is Booming in Japan. Japan already enjoys the world’s second-biggest market in medical devices. percent of the 2014 global medical device market—behind the U.S. Philips, the Dutch electronics and health care corporation, is among the foreign companies attracted to Japan’s market.

Health Care 12

Health Care Industry Pharmaceuticals Content 12

Harvard Business Review

SEPTEMBER 29, 2011

They are not interested in hearing about the technological, regulatory, and societal developments that will determine the long-term, strategic positioning of this company.". They can signal to the market the types of investors they wish to own their shares. CEOs can seek to attract long-term investors in several ways: 1.

Long-term 15

Long-term CEO Short-term Asset Management 15